Skip to content
ABOUT
AUTHOR GUIDELINES
AUTHORS/EDITORS
SUBSCRIPTIONS
CONTACT US
MY ACCOUNT
Facebook
X
LinkedIn
Instagram
Search
×
HOME
PSYCH. BULLETIN
LATEST ISSUE
BLACK BOOK OF DOSING & MONITORING
RATING SCALES
LICENSING INFORMATION
RESOURCES
PSYCHOTROPICS A-Z
PSYCHOPHARMACOLOGY 101
NEWS
Optimizing Treatment Outcomes for Patients With Depression and Generalized Anxiety Disorder
1
x
$
30.00
A Comprehensive Update of Lofexidine for the Management of Opioid Withdrawal Symptoms
1
x
$
30.00
Letter From the Editors: Right Tool, Right Time, Right Reason
1
x
$
0.00
Epidural Analgesia in Ventral Hernia Repair: An Analysis of 30-day Outcomes
1
x
$
30.00
New Developments in the Neurobiological Basis of Anxiety Disorders
1
x
$
30.00
Managing Deep Vein Thrombosis Risk in Oncology Patients Office and Outpatient Settings
1
x
$
10.00
Psychopharmacology Bulletin VOL 37 Supplement No. 2 - Full Issue Stacked PDF
1
x
$
60.00
Graeme F. Mason, PhD: Magnetic Resonance Spectroscopy for Studies of Neurotransmission in Vivo
1
x
$
30.00
Cannabis Pen-Induced Psychosis in a First-Time Adolescent User
1
x
$
30.00
Lithium-Induced Hyperparathyroidism: An Ill-defined Territory (OPEN ACCESS)
1
x
$
0.00
Paroxetine Treatment of Mood Disorders in Women: Premenstrual Dysphoric Disorder and Hot Flashes
1
x
$
30.00
Consequences of 1,4-Butanediol Misuse: A Review
1
x
$
30.00
Vicki L. Ellingrod, PharmD, BCPP: 5-HT2A Receptor Promoter Polymorphism, -1438G/A and Negative Symptom Response to Olanzapine in Schizophrenia
1
x
$
30.00
View Cart
Checkout
Home
Store
“Vicki L. Ellingrod, PharmD, BCPP: 5-HT2A Receptor Promoter Polymorphism, -1438G/A and Negative Symptom Response to Olanzapine in Schizophrenia” has been added to your cart.
View cart
Sort by
Date
Sort by
Name
Sort by
Price
Sort by
Date
Sort by
Popularity
Show
20 Products
Show
20 Products
Show
40 Products
Show
60 Products
Shaina D. Barnes, Pharm D: Isolated Aripiprazole Drug Interaction with Estrogen
$
30.00
Add to cart
Details
Carol Vidal Castro, MD – Reboxetine: An Alternative for Induced Bruxism
$
30.00
Add to cart
Details
Michael E. Thase, MD: Editor’s Letter
$
0.00
Add to cart
Details
Daniel J. Carlat, MD: Commentary on the Treatment Effects of Selegiline Transdermal System on Symptoms of Major Depressive Disorder: A Meta-Analysis of Short-Term, Placebo-Controlled, Efficacy Trials
$
30.00
Add to cart
Details
Branimir Margetic: A Case of Stuttering During Treatment with Levomepromazine
$
30.00
Add to cart
Details
Ahmad Ghanizadeh, MD: Photophobia and Methylphenidate
$
30.00
Add to cart
Details
Takefumi Suzuki, MD, PhD: A Potentially Aborted Neuroleptic Malignant Syndrome Following Seclusion Against Uncontrollable Water Intoxication
$
30.00
Add to cart
Details
Theodore J. Anfinson, MD: Drug Dependence Involving Prednisone:Two Cases and a Review of the Literature
$
30.00
Add to cart
Details
Nienke Dekker, MD: Cessation of Cannabis Use by Patients with Recent-Onset Schizophrenia and Related Disorders
$
30.00
Add to cart
Details
Sumeet Roy, PhD, MBA: Efficacy of Print Advertising for a Bipolar Disorder Study
$
30.00
Add to cart
Details
Eduard Parellada, MD, MSc, PhD: Long-Acting Injectable Risperidone in the Treatment of Schizophrenia in Special Patient Populations
$
30.00
Add to cart
Details
Jodi M. Gonzalez, PhD: Treatment Characteristics and Illness Burden Among European Americans, African Americans, and Latinos in the First 2,000 Patients of the Systematic Treatment Enhancement Program for Bipolar Disorder
$
30.00
Add to cart
Details
Indira Varia, MD: Effect of Mirtazapine Orally Disintegrating Tablets on Health-Related Quality of Life in Elderly Depressed Patients with Comorbid Medical Disorders: A Pilot Study
$
30.00
Add to cart
Details
Vicki L. Ellingrod, PharmD, BCPP: Leptin and Leptin Receptor Gene Polymorphisms and Increases in Body Mass Index (BMI) from Olanzapine Treatment in Persons with Schizophrenia
$
30.00
Add to cart
Details
Claus Rosenberg, MD: Citalopram Versus Amitriptyline in Elderly Depressed Patients with or without Mild Cognitive Dysfunction: A Danish Multicentre Trial in General Practice
$
30.00
Add to cart
Details
Placebo Response in Depression: A Perspective for Clinical Practice
$
30.00
Add to cart
Details
Psychometric Evaluation of a Patient-Rated Troubling Symptom Scale for Generalized Anxiety Disorder Clinical Trials
$
30.00
Add to cart
Details
Developing and Testing Adaptive Treatment Strategies Using Substance-Induced Psychosis as an Example
$
30.00
Add to cart
Details
A Major Change of Prescribing Pattern in Absence of Adequate Evidence: Benzodiazepines Versus Newer Antidepressants in Anxiety Disorders
$
30.00
Add to cart
Details
The Efficacy and Tolerability of Once-Daily Extended Release Quetiapine Fumarate in Hospitalized Patients with Acute Schizophrenia: A 6-Week Randomized, Double-Blind, Placebo-Controlled Study
$
30.00
Add to cart
Details
Previous
1
…
23
24
25
…
44
Next
Page load link
Go to Top
